StreetAlpha
Biocryst Pharmaceuticals Inc · SEC Form 4

BCRX Insider Trading

From SEC Form 410 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Biocryst Pharmaceuticals Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $4.1M sold.

← BCRX stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$4.1M7 sales · 3 insiders
Net−$4.1Mbought minus sold
Planned sales85%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $1.5MDecJanFeb2026-03: sold $1.9MMarApr2026-05: sold $697KMayJunJulAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when BCRX insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an BCRX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every BCRX insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
May 18, 2026Amy E McKeeDirectorSale11,180$8.97$100K31,252May 19Form 4
May 13, 2026Alane P BarnesChief Legal OfficerSale plan62,500$9.54$596K400,703May 15Form 4
Mar 20, 2026Theresa HeggieDirectorSale49,933$10.11$505K65,352Mar 24Form 4
Mar 16, 2026Alane P BarnesChief Legal OfficerSale plan150,000$9.15$1.4M400,703Mar 18Form 4
Dec 22, 2025Alane P BarnesChief Legal OfficerSale plan21,773$7.65$167K398,751Dec 23Form 4
Dec 15, 2025Alane P BarnesChief Legal OfficerSale plan21,210$7.65$162K315,726Dec 16Form 4
Dec 3, 2025Alane P BarnesChief Legal OfficerSale plan161,680$7.20$1.2M345,476Dec 3Form 4
Nov 13, 2025Machelle SandersDirectorSale plan9,600$7.14$69K30,642Nov 17Form 4
Aug 13, 2025Theresa HeggieDirectorSale70,000$8.51$596K65,352Aug 15Form 4
Dec 13, 2024Nancy J HutsonDirectorSale plan7,000$7.54$53K86,638Dec 16Form 4

BCRX insider trading FAQ

Are BCRX insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of BCRX on the open market in 0 trades, and 3 sold $4.1M in 7 trades, 85% of that under pre-arranged trading plans.

When did an BCRX insider last buy shares?

There has been no open market insider purchase of BCRX in the last two years.

When did an BCRX insider last sell shares?

Amy E McKee (Director) sold 11,180 shares for $100K on May 18, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice